Over 40 years of research and 58 clinical studies reviewed, including 27 peer-reviewed trials translated into English, point toward the effectiveness of standardized Saw Palmetto extract.
LAKE MARY, Fla., January 18, 2022--(BUSINESS WIRE)--A recent groundbreaking three-part review published in the journal Uro, analyzes and provides important new insights about the benefits of a standardized saw palmetto extract used in men with lower urinary tract symptoms (LUTS) associated with an enlarged prostate. Authored by Stephen B. Strum, M.D., board-certified oncologist, specializing in prostate cancer, this first-ever, comprehensive global review includes a detailed analysis of 58 human intervention trials spanning over 40 years of clinical research that were evaluable for the effectiveness of a standardized saw palmetto extract for men with LUTS.
Following his analysis of the studies, Dr. Strum concludes that men with LUTS showed improvement in peak urinary flow rate, improvement in symptoms (measured by International Prostate Symptom Score, IPSS), improvement in quality of life (QoL) and delay of clinical progression of symptoms after taking 320 mg of a high-quality lipidosterolic extract of Serenoa repens (saw palmetto extract) for at least three months. A high-quality saw palmetto extract is one that meets the standardized profile set by agencies like the European Medicines Agency (EMA) or the United States Pharmacopeia (USP). Among the 58 evaluable studies reviewed, 55 studies confirmed a benefit that came with the use of saw palmetto extract. The review highlighted that crushed dried saw palmetto berry powder, the predominant preparation available in the USA, is not comparable to the clinically effective dose of 320 mg/day lipidosterolic extract of saw palmetto.
"This review confirms what many already believed to be true about saw palmetto extract," said J. Curtis Nickel, Professor of Urology in Kingston, Canada. "In some countries, this respected supplement is available by prescription, and is part of an accepted care regimen for the urinary symptoms associated with prostate enlargement. This 2021 review is a significant contribution to our understanding of the benefits of a high-quality saw palmetto extract and will help us provide better guidance and care to our patients, especially during the watchful waiting phase when more aggressive therapy is not required. There is value in considering adding a saw palmetto extract supplement to the daily healthcare regimen of men suffering from urinary symptoms associated with benign prostatic hyperplasia (BPH)."
The Urology Care Foundation reports that BPH impacts about half of men aged 50 to 60 and 90% of men over the age of 801 . Many of these patients will experience lower urinary tract symptoms, such as increased urination, sudden urgency and a weak stream. These symptoms can reduce the overall quality of life, including disrupting sleep. Data from the IQVIA Longitudinal Prescription and Medical Claims Database for 12 months ending January 2021, indicates that almost half of these patients are typically managed by watchful waiting which involves lifestyle changes and symptom monitoring. The evidence from this comprehensive global review suggests that a standardized saw palmetto extract can be another beneficial tool for these patients.
Saw palmetto is a dwarf palm tree that is native to the southeast United States, the only place in the world where it grows. Native Americans have used saw palmetto berries as a food source and as a herbal medicine for hundreds of years. Today in Europe, certain saw palmetto oil extracts are recognized as safe and effective by the EMA.
Located in Lake Mary, FL, Flomentum Health is committed to providing prostate and urinary health solutions which are sourced from nature, supported by science, responsibly manufactured, independently verified for quality, which healthcare professionals confidently can recommend. Flomentum is the first and only USP Verified prostate health supplement.
For more information, please visit www.flomentum.com.
Urology Care Foundation. (2021). What is Benign Prostatic Hyperplasia (BPH)? Urology Care Foundation. https://www.urologyhealth.org/urology-a-z/b/benign-prostatic-hyperplasia-(bph)
View source version on businesswire.com: https://www.businesswire.com/news/home/20220118005546/en/
Media: Alex McClung, JPA Health amcclung@jpa.com (202) 769-5046
Ian Shepherdson, chief economist and founder of research consulting firm Pantheon Macroeconomics, is predicting a dramatic fall in the pace of home sales this year. In a research note, he projected that existing-home sales will drop roughly 25% from the annual pace of 6.02 million set in February to a rate of 4.5 million by the end of summer. “The housing market is in the early stages of a substantial downshift in activity, which will trigger a steep decline in the rate of increase of home prices, starting perhaps as soon as the spring,” Shepherdson wrote in a research note distributed Sunday.
Cowen Managing Director & Senior Research Analyst Cai von Rumohr joins Yahoo Finance Live to discuss the Boeing jetliner that crashed in southern China, China's decision to ground all Boeing 737 planes, and consumer perceptions of the tragedy.
One of the biggest worries associated with retirement planning is making sure you have enough money tucked away. While some people might aim to save $1 million or even $2 million for the future, your goal might be to save … Continue reading → The post How Long Will $600,000 Last in Retirement? appeared first on SmartAsset Blog.
Shares of Novavax (NASDAQ: NVAX) were slipping 3% as of 11:21 a.m. ET on Monday after falling as much as 6.3% earlier in the day. The decline appeared to be linked to a disappointing uptake for the company's COVID-19 vaccine in Germany. European news organization The Local reported Monday morning that Germans who are skeptical about vaccination haven't been won over by Novavax's vaccine, branded as Nuvaxovid.
NeuroSense Therapeutics Ltd (NASDAQ: NRSN) has received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects. PrimeC is a novel extended-release oral formulation composed of a fixed-dose combination of ciprofloxacin and celecoxib. PrimeC targets several key mechanisms of amyotrophic lateral sclerosis (ALS) that contribute to motor neuron degeneration, inflammation, iron accumulation, and impaired RNA regulation to inhibit ALS's progression potentially. P
After a stunning rally last week, Nio (NYSE: NIO) stock opened Monday on a quiet note and was trading down 5.5% as of 10:45 a.m. ET. An analyst downgrade just ahead of earnings is hitting investor sentiment even as Nio just confirmed it will not follow the footsteps of rival Tesla in increasing prices of its electric vehicles (EVs). Nio is set to report its fourth-quarter and full year 2021 earnings after market close on Thursday.
Elon Musk has arrived in Europe where he is to launch the beginning of a new era of Tesla on the continent. The electric vehicle maker which produced nearly a million vehicles in 2021 wants to step up a gear and produce more in the coming years. To achieve this, Tesla built a Gigafactory near Berlin.
After Russia's invasion of Ukraine sent global wheat futures soaring, U.S. farmer Vance Ehmke was eager to sell his grain. Local prices shot up roughly 30% to nearly $12 a bushel, about the highest Ehmke could recall in 45 years of farming near the western Kansas town of Healy. Instead of reaping a windfall, Ehmke found a commodities market turned upside down.
When markets turn volatile, it’s natural to look for some signal to cut through the additional noise and to clarify the stocks that are set for long-term gains. One signal that some investors latch onto is the trend of insider trading. CEOs, CFOs, COOs, and Board members all have access to the deeper workings of their companies, and their positions hold them responsible for company performance. This gives them a vested stake in the company – and it also gives them a much clearer view of their co
Warren Buffett has made a few power moves in March. Here's what these big deals signal to investors.
Moves in the stock show the market's mixed instincts. Investors are stalking bargains one minute, and shunning high-multiple software shares the next.
Both claim the company is violating the Unfair Sales Act.
The Chinese government has not made life easy for ecommerce giant Alibaba (BABA). Regulatory crackdowns and an almost hostile approach have been de rigueur over the past couple of years. But a slowing Chinese economy has caused a bit of a rethink at the higher echelons of Chinese decision-making. The government is preparing a course of action that will boost its ailing economy. According to a report by the Xinhua news agency, the government will “actively release policies favorable to markets” a
(Bloomberg) -- The U.S. bond market reeled further on Tuesday, extending Monday’s declines after Federal Reserve Chair Jerome Powell’s aggressive rate hike comments drove yields on short-dated Treasuries to one of their biggest daily jumps of the past decade.Most Read from BloombergChina Plane Crash Update: Wreckage Found, Airline Grounds JetsChina Eastern Boeing 737 Jet Crashes With More Than 130 on BoardChina Jet’s Nosedive From 29,000 Feet Baffles Crash SpecialistsXi Risks Leaving China Isola
Shares of cruise company Carnival (NYSE: CCL) fell 2.9% by noon ET on Monday after the company confirmed that it will provide a first-quarter 2022 business update on Tuesday morning, following release of its first-quarter earnings report. The business update announcement was the only really relevant news about Carnival today. For what it's worth, expectations for Carnival in the first quarter are already pretty low.
Many issues face investors in the company, above and beyond the sharp falloff of interest in Truth Social
The price of fertilizer is up more than 40% in the last month. This will hit the Middle East especially hard, while war rages in Ukraine. It's a tinderbox.
Chinese stocks fell hard Monday, including giants such as Alibaba, Baidu and JD.com, over concerns about more disruption.
Costco always plans for a rainy day. While the warehouse club steadily expands and returns capital to shareholders via dividends (and occasional special dividends), it guards and uses its cash balance carefully. Unlike Amazon and Walmart , Costco has not built out a massive two-day, next-day, and same-day delivery infrastructure.
The enigmatic CEO hinted the so-called X holding—which could include SpaceX and the Boring Company alongside Tesla—may be part of his first major strategic update in six years.